The $170m deal Perrigo Company PLC made 16 months ago to expand its infant formula production capacity also brought the heaviest drag on the firm’s earnings due to extensive remediation needed at the facility it acquired.
Perrigo executives didn’t obscure or otherwise attempt to diminish the significance of the challenge to restarting sales growth in the formula market during the Dublin-based
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?